These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 20018383

  • 21. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 22. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
    Bannai H, Nemoto M, Tsujimura K, Yamanaka T, Kokado H, Kondo T, Matsumura T.
    Vet Microbiol; 2018 Aug 24; 222():18-24. PubMed ID: 30080668
    [Abstract] [Full Text] [Related]

  • 23. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE, Raidal SL, Pecenpetelovska G, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):97-108. PubMed ID: 16504306
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
    Patel JR, Didlick S, Bateman H.
    Equine Vet J; 2004 Jul 15; 36(5):447-51. PubMed ID: 15253088
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.
    Soboll Hussey G, Hussey SB, Wagner B, Horohov DW, Van de Walle GR, Osterrieder N, Goehring LS, Rao S, Lunn DP.
    Vet Res; 2011 Feb 07; 42(1):23. PubMed ID: 21314906
    [Abstract] [Full Text] [Related]

  • 26. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL, Wimer CL, Perkins G, Babasyan S, Freer H, Watts C, Rollins A, Osterrieder N, Wagner B.
    BMC Vet Res; 2018 Aug 22; 14(1):245. PubMed ID: 30134896
    [Abstract] [Full Text] [Related]

  • 27. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
    Paillot R, Daly JM, Luce R, Montesso F, Davis-Poynter N, Hannant D, Kydd JH.
    Dev Comp Immunol; 2007 Aug 22; 31(2):202-14. PubMed ID: 16824599
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Immune horses rapidly increase antileukoproteinase and lack type I interferon secretion during mucosal innate immune responses against equine herpesvirus type 1.
    Holmes CM, Babasyan S, Eady N, Schnabel CL, Wagner B.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0109224. PubMed ID: 39162558
    [Abstract] [Full Text] [Related]

  • 31. Equine herpesvirus-1-specific interferon gamma (IFNgamma) synthesis by peripheral blood mononuclear cells in thoroughbred horses.
    Luce R, Shepherd M, Paillot R, Blacklawst B, Wood JL, Kydd JH.
    Equine Vet J; 2007 May 03; 39(3):202-9. PubMed ID: 17520969
    [Abstract] [Full Text] [Related]

  • 32. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR, Bateman H, Williams J, Didlick S.
    Vet Microbiol; 2003 Jan 02; 91(1):23-39. PubMed ID: 12441229
    [Abstract] [Full Text] [Related]

  • 33. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K, Caij B, Pensaert M, Nauwynck H.
    Vet Microbiol; 2006 Mar 31; 113(3-4):265-73. PubMed ID: 16387454
    [Abstract] [Full Text] [Related]

  • 34. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH, Townsend HG, Hannant D.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):15-30. PubMed ID: 16476492
    [Abstract] [Full Text] [Related]

  • 35. Response of ponies to adjuvanted EHV-1 whole virus vaccine and challenge with virus of the homologous strain.
    Dolby CA, Hannant D, Mumford JA.
    Br Vet J; 1995 May 15; 151(1):27-37. PubMed ID: 7735868
    [Abstract] [Full Text] [Related]

  • 36. Detection and quantification of equine herpesvirus-1 viremia and nasal shedding by real-time polymerase chain reaction.
    Hussey SB, Clark R, Lunn KF, Breathnach C, Soboll G, Whalley JM, Lunn DP.
    J Vet Diagn Invest; 2006 Jul 15; 18(4):335-42. PubMed ID: 16921871
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):67-80. PubMed ID: 16476488
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.